OmniAb Inc reports results for the quarter ended in June - Earnings Summary

OmniAB

09/08/2024 20:10

* OmniAb Inc  OABI.OQ  reported a quarterly adjusted loss
of 13
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -15
cents.  The mean expectation of eight analysts for the quarter
was for a loss of 17 cents per share. Wall Street expected
results to range from -20 cents to -13 cents per share.
    * Revenue rose 9.6% to $7.61 million from a year ago;
analysts
expected $5.77 million. 
    * OmniAb Inc's reported EPS for the quarter was a loss of 13
cents​.
    * The company reported a quarterly loss of $13.63 million.
    * OmniAb Inc shares had risen by 14.4% this quarter and
lost 30.5%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for OmniAb Inc is
$10.00 
This summary was machine generated from LSEG data August 9 at
07:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.17          -0.13          Beat
 Mar. 31 2024      -0.16          -0.19          Missed
 Dec. 31 2023      -0.15          -0.14          Beat
 Sep. 30 2023      -0.14          -0.16          Missed